Skip to main content
. 2020 Oct 27;3(10):e2019304. doi: 10.1001/jamanetworkopen.2020.19304

Figure 2. Endothelial Cell Phosphorylated–Focal Adhesion Kinase (EC-pY397-FAK) as a Prognostic Factor .

Figure 2.

Rates of disease-free survival for low and high EC-pY397-FAK expression levels in all patients (A), estrogen receptor (ER)-positive patients (B), and ER-negative patients (C). (D) Disease-free survival rates in patients with low EC-pY397-FAK expression levels combined with low and high blood vessel density (BVD). (E) Disease-free survival rates of patients with low EC-pY397-FAK and low tumor cell (TC)-pY397-FAK expression levels combined with low and high BVD.